Fingerprint
Dive into the research topics of 'Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation
Marco Galluzzo, Marina Talamonti, Clara De Simone, Simone D’Adamio, Gaia Moretta, Sara Tambone, Giacomo Caldarola, Maria Concetta Fargnoli, Ketty Peris, Luca Bianchi
Research output: Contribution to journal › Article
27
Citations
(Scopus)